Your browser doesn't support javascript.
loading
FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls.
Holzgreve, Adrien; Nitschmann, Alexander; Maier, Sebastian H; Büttner, Marcel; Schönecker, Stephan; Marschner, Sebastian N; Fleischmann, Daniel F; Corradini, Stefanie; Belka, Claus; la Fougère, Christian; Bodensohn, Raphael; Albert, Nathalie L; Niyazi, Maximilian.
Affiliation
  • Holzgreve A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA. Electronic address: Adrien.Holzgreve@med.lmu.de.
  • Nitschmann A; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Maier SH; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Büttner M; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Schönecker S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Marschner SN; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Fleischmann DF; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Corradini S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany; German Cancer Consortium (DKTK), Munich, Germany.
  • la Fougère C; Department of Nuclear Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Bodensohn R; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany; German Cancer Consortium (DKTK), Munich, Germany.
  • Niyazi M; Bavarian Cancer Research Center (BZKF), Munich, Germany; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Tübingen, Germany.
Radiother Oncol ; 198: 110386, 2024 09.
Article in En | MEDLINE | ID: mdl-38880414
ABSTRACT
PET is increasingly used for target volume definition in the radiotherapy of glioblastoma, as endorsed by the 2023 ESTRO-EANO guidelines. In view of its growing adoption into clinical practice and upcoming PET-based multi-center trials, this paper aims to assist in overcoming common pitfalls of FET PET-based target delineation in glioblastoma.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Planning, Computer-Assisted / Brain Neoplasms / Glioblastoma / Positron-Emission Tomography Limits: Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Country of publication: Irlanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy Planning, Computer-Assisted / Brain Neoplasms / Glioblastoma / Positron-Emission Tomography Limits: Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Country of publication: Irlanda